The mission of NU-MED is to design, develop, and market technologies in the medical device field. Our technologies will focus on market niches in high growth trend areas. We hope each developed technology will fill a current need in medical procedures by improving upon an existing technology or devi... The mission of NU-MED is to design, develop, and market technologies in the medical device field. Our technologies will focus on market niches in high growth trend areas. We hope each developed technology will fill a current need in medical procedures by improving upon an existing technology or device, or by designing a device to serve a need that is clearly defined and acknowledged by medical professionals. Show more
Nu-Med Plusβ Proprietary Technology Aims to Increase Longevity and Safety of Banked Blood Supply and Reduce Side Effects of Blood Transfusions Nitric Oxide Blood...
Sun, Sep 01, 2013 12:00 - Nu-Med Plus Inc. (NUMD: OTCQB) - Piggyback Qualified - Effective Sun, Sep 01, 2013, NUMD is designated with the status of piggyback qualified. Piggyback qualification...
Fri, Aug 02, 2013 12:00 - Nu-Med Plus Inc. (NUMD: FINRA BB Only) - Tier Change - The symbol, NUMD, no longer is classified as FINRA BB Only. As of Fri, Aug 02, 2013, NUMD resides in the OTCQB...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.000925 | 5.58069381599 | 0.016575 | 0.0175 | 0.0126 | 2047 | 0.01310648 | CS |
4 | 0.00182 | 11.6071428571 | 0.01568 | 0.0198 | 0.0126 | 17971 | 0.01556207 | CS |
12 | -0.0325 | -65 | 0.05 | 0.0639 | 0.0126 | 44020 | 0.02895519 | CS |
26 | -0.04462 | -71.8287186091 | 0.06212 | 0.0799 | 0.0126 | 26114 | 0.0339676 | CS |
52 | -0.02295 | -56.7367119901 | 0.04045 | 0.09 | 0.0126 | 38599 | 0.04725923 | CS |
156 | -0.0175 | -50 | 0.035 | 0.09 | 0.009 | 170281 | 0.03116507 | CS |
260 | -0.4325 | -96.1111111111 | 0.45 | 2.5 | 0.009 | 112084 | 0.04034774 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.